These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 12663938)

  • 1. Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.
    Hamel E
    Cell Biochem Biophys; 2003; 38(1):1-22. PubMed ID: 12663938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site.
    Batra JK; Powers LJ; Hess FD; Hamel E
    Cancer Res; 1986 Apr; 46(4 Pt 2):1889-93. PubMed ID: 3948171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers.
    Hamel E; Lin CM; Flynn E; D'Amato RJ
    Biochemistry; 1996 Jan; 35(4):1304-10. PubMed ID: 8573587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data.
    Paull KD; Lin CM; Malspeis L; Hamel E
    Cancer Res; 1992 Jul; 52(14):3892-900. PubMed ID: 1617665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel.
    Dabydeen DA; Florence GJ; Paterson I; Hamel E
    Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural organic compounds that affect to microtubule functions.
    Iwasaki S
    Yakugaku Zasshi; 1998 Apr; 118(4):112-26. PubMed ID: 9564789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines.
    Chi DM; Shahrik LK; Ho HH; Hamel E
    Cancer Res; 1989 Mar; 49(6):1344-8. PubMed ID: 2924291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B; Panda D; Gupta S; Banerjee M
    Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
    Blokhin AV; Yoo HD; Geralds RS; Nagle DG; Gerwick WH; Hamel E
    Mol Pharmacol; 1995 Sep; 48(3):523-31. PubMed ID: 7565634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.
    Rappl C; Barbier P; Bourgarel-Rey V; Grégoire C; Gilli R; Carre M; Combes S; Finet JP; Peyrot V
    Biochemistry; 2006 Aug; 45(30):9210-8. PubMed ID: 16866367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Prinz H; Ishii Y; Hirano T; Stoiber T; Camacho Gomez JA; Schmidt P; Düssmann H; Burger AM; Prehn JH; Günther EG; Unger E; Umezawa K
    J Med Chem; 2003 Jul; 46(15):3382-94. PubMed ID: 12852768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
    Lin CM; Singh SB; Chu PS; Dempcy RO; Schmidt JM; Pettit GR; Hamel E
    Mol Pharmacol; 1988 Aug; 34(2):200-8. PubMed ID: 3412321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of antimitotic peptides and depsipeptides with tubulin.
    Hamel E
    Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel imidazole-based combretastatin A-4 analogues: evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin.
    Bellina F; Cauteruccio S; Monti S; Rossi R
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5757-62. PubMed ID: 16950621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity.
    Cao TM; Durrant D; Tripathi A; Liu J; Tsai S; Kellogg GE; Simoni D; Lee RM
    Am J Hematol; 2008 May; 83(5):390-7. PubMed ID: 18175355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
    J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
    Nguyen TL; McGrath C; Hermone AR; Burnett JC; Zaharevitz DW; Day BW; Wipf P; Hamel E; Gussio R
    J Med Chem; 2005 Sep; 48(19):6107-16. PubMed ID: 16162011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.